COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE
$3,667,392N01FY2021AINIH
Duke University, Durham NC
Investigators
Abstract
To design, implement and manage a Phase I clinical trial to advance research on a universal influenza vaccine developed by the NIAID Collaborative Influenza Vaccine Innovation Centers.
View original record on NIH RePORTER →